Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

Abstract Background Among patients with colorectal cancer (CRC) treated with oxaliplatin (L-OHP)-based chemotherapy, delayed chemotherapy-induced nausea and vomiting (CINV) have not been well controlled. Methods We pooled data from two prospective observational studies in Japan and one phase III cli...

Full description

Bibliographic Details
Main Authors: Mototsugu Shimokawa, Toshinobu Hayashi, Junichi Nishimura, Taroh Satoh, Mutsumi Fukunaga, Reiko Matsui, Yasushi Tsuji, Fumitaka Mizuki, Takahiro Kogawa
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
Chemotherapy
Nausea
Vomiting
Colorectal cancer
Antiemetics
Oxaliplatin
Online Access:https://doi.org/10.1186/s12885-021-08860-y

Internet

https://doi.org/10.1186/s12885-021-08860-y

Similar Items